Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

NCT00539162 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

8000

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

BEHAVIORAL: Questionnaire

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]